Atropine for Myopia

Atropine 0.01% has proven to be effective in diminishing progression of myopia in children¹.

A child is eligible if:

• Ages 6-12 years
• Progression >1 diopter over one year interval.
• Progression 0.5-1 diopter, if a significant family history of high myopia.

Child will receive one drop of the Atropine 0.01% onto each eye at bedtime.  This therapy continues for 2 years and then tapered off.

Initial follow up appointment 3 months after initiating the eyedrops.

Subsequent follow up every 9 months.

Increasing child’s daylight exposure and reducing intense periods of near work may be helpful in decreasing myopic progression as well.

1.  Chia A, Lu QS, Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops . 2016 Feb;123(2):391-9